Cardiol Therapeutics Inc. (CRDL)
USD 1.14
(1.79%)
USD 1.14
(1.79%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -29.59 Million CAD | 40.96% |
| 2022 | -41.15 Million CAD | -10.75% |
| 2021 | -38.44 Million CAD | -122.08% |
| 2020 | -20.46 Million CAD | -51.69% |
| 2019 | -11.76 Million CAD | -84.04% |
| 2018 | -7.29 Million CAD | -375.2% |
| 2017 | -1.5 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -8.34 Million CAD | -4.8% |
| 2024 Q2 | -7.67 Million CAD | 7.96% |
| 2023 Q3 | -8.65 Million CAD | -89.29% |
| 2023 FY | - CAD | 41.07% |
| 2023 Q1 | -7.87 Million CAD | 21.47% |
| 2023 Q2 | -4.57 Million CAD | 41.99% |
| 2023 Q4 | -7.96 Million CAD | 7.97% |
| 2022 FY | - CAD | -10.75% |
| 2022 Q1 | -10.49 Million CAD | 47.08% |
| 2022 Q4 | -10.03 Million CAD | 43.83% |
| 2022 Q3 | -17.86 Million CAD | -52.26% |
| 2022 Q2 | -11.72 Million CAD | -11.75% |
| 2021 Q3 | -10.23 Million CAD | -64.89% |
| 2021 Q4 | -19.83 Million CAD | -93.84% |
| 2021 Q2 | -6.2 Million CAD | 30.89% |
| 2021 FY | - CAD | -122.08% |
| 2021 Q1 | -8.97 Million CAD | 5.89% |
| 2020 FY | - CAD | -51.69% |
| 2020 Q3 | -4.33 Million CAD | -23.27% |
| 2020 Q2 | -3.51 Million CAD | -17.34% |
| 2020 Q1 | -2.99 Million CAD | -0.41% |
| 2020 Q4 | -9.54 Million CAD | -120.34% |
| 2019 Q3 | -3.48 Million CAD | 2.42% |
| 2019 FY | - CAD | -84.04% |
| 2019 Q4 | -2.98 Million CAD | 14.41% |
| 2019 Q1 | -3.39 Million CAD | -6.54% |
| 2019 Q2 | -3.56 Million CAD | -5.01% |
| 2018 Q1 | -510.47 Thousand CAD | 6.07% |
| 2018 Q3 | -2.37 Million CAD | -93.64% |
| 2018 Q4 | -3.19 Million CAD | -34.46% |
| 2018 FY | - CAD | -375.2% |
| 2018 Q2 | -1.22 Million CAD | -140.03% |
| 2017 Q2 | -393.12 Thousand CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | -543.48 Thousand CAD | -10.6% |
| 2017 Q3 | -491.4 Thousand CAD | -25.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -150.1 Million USD | 80.287% |
| Theratechnologies Inc. | -10.31 Million USD | -186.927% |
| Safety Shot Inc | -12.18 Million USD | -142.838% |
| Cosmos Health Inc. | -17.06 Million USD | -73.43% |
| Cronos Group Inc. | -72.14 Million USD | 58.987% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 96.801% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 17.992% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 182.124% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -820.361% |
| ProPhase Labs, Inc. | -14.82 Million USD | -99.57% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -553.928% |
| Dynavax Technologies Corporation | 9.66 Million USD | 406.127% |
| Radius Health, Inc. | 38.31 Million USD | 177.239% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -1158.618% |
| Alvotech | -484.86 Million USD | 93.897% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -673.719% |
| Alpha Teknova, Inc. | -25.53 Million USD | -15.863% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 81.373% |
| SCYNEXIS, Inc. | 73.47 Million USD | 140.27% |
| Harrow Health, Inc. | 9.72 Million USD | 404.332% |
| Biofrontera Inc. | -18.45 Million USD | -60.355% |
| DURECT Corporation | -24.68 Million USD | -19.876% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 130.114% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 127.068% |
| OptiNose, Inc. | -15.55 Million USD | -90.254% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 212.655% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 2603.404% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -4062.656% |
| SIGA Technologies, Inc. | 84.15 Million USD | 135.16% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 3744.118% |
| Shineco, Inc. | -26.55 Million USD | -11.435% |
| Phibro Animal Health Corporation | 84.6 Million USD | 134.974% |
| Procaps Group S.A. | 104.02 Million USD | 128.445% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -252.223% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -717.946% |
| Viatris Inc. | 3.51 Billion USD | 100.841% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -673.719% |
| Rockwell Medical, Inc. | -4.69 Million USD | -530.384% |
| Incannex Healthcare Limited | -18.5 Million USD | -59.913% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -2823.937% |
| Tilray Brands, Inc. | -72.84 Million USD | 59.378% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 109.597% |
| PetIQ, Inc. | 81.48 Million USD | 136.313% |
| Silver Spike Investment Corp. | 7.34 Million USD | 503.131% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 107.111% |
| Journey Medical Corporation | 1.92 Million USD | 1640.356% |
| Alimera Sciences, Inc. | 7.27 Million USD | 506.683% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -602.544% |
| Assertio Holdings, Inc. | -222.44 Million USD | 86.698% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -641.489% |
| Embecta Corp. | 245.4 Million USD | 112.058% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -47.724% |
| Procaps Group, S.A. | 104.02 Million USD | 128.445% |
| PainReform Ltd. | -9.56 Million USD | -209.23% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 80.157% |
| Hempacco Co., Inc. | -12.77 Million USD | -131.658% |
| Talphera, Inc. | -9.84 Million USD | -200.653% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 118.165% |
| Alvotech | -484.86 Million USD | 93.897% |
| Lantheus Holdings, Inc. | 491 Million USD | 106.026% |
| Kamada Ltd. | 21.53 Million USD | 237.412% |
| Indivior PLC | 66 Million USD | 144.834% |
| Currenc Group, Inc. | -1.9 Million USD | -1456.911% |
| Evoke Pharma, Inc. | -7.29 Million USD | -305.774% |
| Flora Growth Corp. | -45.87 Million USD | 35.491% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -47.724% |
| Evolus, Inc. | -41.81 Million USD | 29.227% |
| HUTCHMED (China) Limited | 25.52 Million USD | 215.913% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 112.255% |
| Akanda Corp. | -27.73 Million USD | -6.687% |